GRANT PICKERING - 09 Mar 2026 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
Grant Pickering, by /s/ Peter N. Efremenko, Attorney-In-Fact
Issuer symbol
PCVX
Transactions as of
09 Mar 2026
Net transactions value
$0
Form type
4
Filing time
11 Mar 2026, 17:24:54 UTC
Previous filing
02 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
PICKERING GRANT CHIEF EXECUTIVE OFFICER, Director C/O VAXCYTE, INC., 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS Grant Pickering, by /s/ Peter N. Efremenko, Attorney-In-Fact 11 Mar 2026 0001258693

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Tax liability -3,685 -0.74% $59.32* 496,939 09 Mar 2026 Direct F1
holding PCVX Common Stock 136,215 09 Mar 2026 By Children's Trust F2
holding PCVX Common Stock 136,215 09 Mar 2026 By Children's Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. No other shares of common stock subject to the restrictions on transfer set forth in a Lock-Up Agreement dated January 29, 2026 were sold by the Reporting Person.
F2 Shares are held directly by a trust for the benefit of the Reporting Person's son.
F3 Shares are held directly by a trust for the benefit of the Reporting Person's daughter.